Temat: "ETS" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: ELK1/MTOR/S6K1 Pathway Contributes to Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer.
Autorzy:: Zhao L; Department of Pathology and Genomic Medicine, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Wang Y; Department of Pathology and Genomic Medicine, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Sun X; Department of Pathology and Genomic Medicine, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Zhang X; Department of Medicine, Center for Translational Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Simone N; Department of Radiation Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
He J; Department of Pathology and Genomic Medicine, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 17; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 17.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
ets-Domain Protein Elk-1*
Gefitinib*/pharmacology
Gefitinib*/therapeutic use
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Tyrosine Kinase Inhibitors*/pharmacology
Tyrosine Kinase Inhibitors*/therapeutic use
Animals ; Humans ; Mice ; Cell Line, Tumor ; Cell Proliferation ; Drug Resistance, Neoplasm/genetics ; ErbB Receptors/metabolism ; Mice, Nude ; Ribosomal Protein S6 Kinases ; RNA, Small Interfering/pharmacology ; Sirolimus/pharmacology ; TOR Serine-Threonine Kinases/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Exosomal miR-361-3p promotes the viability of breast cancer cells by targeting ETV7 and BATF2 to upregulate the PAI-1/ERK pathway.
Autorzy:: Li Y; Breast center, Department of Thyroid-Breast-Hernia Surgery, Department of General Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Fan L; Breast center, Department of Thyroid-Breast-Hernia Surgery, Department of General Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Yan A; The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology of National Health Commission, Beijing, People's Republic of China.
Ren X; Breast center, Department of Thyroid-Breast-Hernia Surgery, Department of General Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.
Zhao Y; The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology of National Health Commission, Beijing, People's Republic of China.
Hua B; Breast center, Department of Thyroid-Breast-Hernia Surgery, Department of General Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Jan 28; Vol. 22 (1), pp. 112. Date of Electronic Publication: 2024 Jan 28.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Exosomes*/metabolism
MicroRNAs*/genetics
Proto-Oncogene Proteins c-ets*/genetics
Basic-Leucine Zipper Transcription Factors*/genetics
Animals ; Female ; Humans ; Mice ; Cell Line, Tumor ; Cell Proliferation/genetics ; MAP Kinase Signaling System ; Plasminogen Activator Inhibitor 1/metabolism ; Tumor Suppressor Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: The Elk-3 target Abhd10 ameliorates hepatotoxic injury and fibrosis in alcoholic liver disease.
Autorzy:: Li TZ; Department of Molecular Biology, College of Basic Medical Science, Chifeng University, Chifeng, 024000, China. .
Bai CY; Department of Molecular Biology, College of Basic Medical Science, Chifeng University, Chifeng, 024000, China.
Wu B; Department of Tissue and Embryology, College of Basic Medical Science, Chifeng University, Chifeng, 024000, China.
Zhang CY; Department of Pharmacy, College of Basic Medical Science, Chifeng University, Chifeng, 024000, China.
Wang WT; Department of Pathogenic Biology, College of Basic Medical Science, Chifeng University, Chifeng, 024000, China.
Shi TW; Department of Molecular Biology, College of Basic Medical Science, Chifeng University, Chifeng, 024000, China.
Zhou J; Department of Molecular Biology, College of Basic Medical Science, Chifeng University, Chifeng, 024000, China.; Pokaż więcej
Corporate Authors:: SIRIGULENG
Źródło:: Communications biology [Commun Biol] 2023 Jul 03; Vol. 6 (1), pp. 682. Date of Electronic Publication: 2023 Jul 03.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Liver Diseases, Alcoholic*/genetics
Esterases*/genetics
Proto-Oncogene Proteins c-ets*/genetics
Animals ; Mice ; Epidermal Growth Factor ; Fibrosis ; Liver Cirrhosis ; Transcription Factors ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Identification and characterization of novel ETV4 splice variants in prostate cancer.
Autorzy:: Cosi I; Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Viale Pieraccini 6, 50139, Florence, Italy.; ICCOM - National Research Council, Sesto Fiorentino, Florence, Italy.
Moccia A; Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Viale Pieraccini 6, 50139, Florence, Italy.
Pescucci C; Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Viale Pieraccini 6, 50139, Florence, Italy.
Munagala U; Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Viale Pieraccini 6, 50139, Florence, Italy.
Di Giorgio S; Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Viale Pieraccini 6, 50139, Florence, Italy.
Sineo I; Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Viale Pieraccini 6, 50139, Florence, Italy.
Conticello SG; Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Viale Pieraccini 6, 50139, Florence, Italy.; IFC - National Research Council, Pisa, Italy.
Notaro R; Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Viale Pieraccini 6, 50139, Florence, Italy.; IFC - National Research Council, Pisa, Italy.
De Angioletti M; Core Research Laboratory, Istituto per lo Studio, la Prevenzione e la Rete Oncologica (ISPRO), Viale Pieraccini 6, 50139, Florence, Italy. .; ICCOM - National Research Council, Sesto Fiorentino, Florence, Italy. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Mar 31; Vol. 13 (1), pp. 5267. Date of Electronic Publication: 2023 Mar 31.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Prostatic Neoplasms*/pathology
Proto-Oncogene Proteins c-ets*/genetics
Proto-Oncogene Proteins c-ets*/metabolism
Humans ; Male ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic ; Proto-Oncogene Proteins/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Small-molecule α-lipoic acid targets ELK1 to balance human neutrophil and erythrocyte differentiation.
Autorzy:: Zhang Y; Department of Immunology, School of Basic Medical Sciences, Chengdu Medical College, Xindu Road 783, Chengdu, 610500, China.; Center for Stem Cell Research and Application, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chengdu, China.
Zhou Y; Center for Stem Cell Research and Application, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chengdu, China.
Li X; Center for Stem Cell Research and Application, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chengdu, China.
Pan X; Center for Stem Cell Research and Application, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chengdu, China.
Bai J; Center for Stem Cell Research and Application, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chengdu, China.
Chen Y; Center for Stem Cell Research and Application, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chengdu, China.
Lai Z; Sichuan Cord Blood Bank, Chengdu, China.
Chen Q; Center for Stem Cell Research and Application, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chengdu, China.
Ma F; Center for Stem Cell Research and Application, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chengdu, China. .
Dong Y; Department of Immunology, School of Basic Medical Sciences, Chengdu Medical College, Xindu Road 783, Chengdu, 610500, China. .; Center for Stem Cell Research and Application, Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Chengdu, China. .; Pokaż więcej
Źródło:: Stem cell research & therapy [Stem Cell Res Ther] 2024 Apr 08; Vol. 15 (1), pp. 100. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:: Journal Article
MeSH Terms:: Thioctic Acid*
Leukemia*
Humans ; Mice ; Animals ; Erythropoiesis ; Neutrophils/metabolism ; Interleukin-3 Receptor alpha Subunit ; ets-Domain Protein Elk-1/genetics ; Antigens, CD34/genetics ; Antigens, CD34/metabolism ; Cell Differentiation/genetics ; Erythrocytes ; Hypoxia ; Protein Isoforms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: High expression of RTEL1 predicates worse progression in gliomas and promotes tumorigenesis through JNK/ELK1 cascade.
Autorzy:: Wang G; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, P.R. China.; Department of Oncology, Xi'an Central Hospital, 710061, Xi'an, P.R. China.
Ren X; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, P.R. China.
Li J; Department of Respiratory Disease, Xi'an Central Hospital, 710061, Xi'an, P.R. China.
Cui R; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, P.R. China.
Zhao X; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, P.R. China.
Sui F; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, P.R. China.
Liu J; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, P.R. China.
Chen P; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, P.R. China.
Yang Q; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, P.R. China.
Ji M; Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, P.R. China.
Hou P; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, P.R. China.
Gao K; Department of Neurosurgery, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China. .
Qu Y; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, P.R. China. .; Department of Radiation Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Mar 26; Vol. 24 (1), pp. 385. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:: Journal Article
MeSH Terms:: Glioma*/pathology
Brain Neoplasms*/genetics
Humans ; Cell Transformation, Neoplastic/genetics ; Oncogenes ; Biomarkers ; Cell Proliferation ; ets-Domain Protein Elk-1/genetics ; DNA Helicases/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Genome-wide identification and characteristic analysis of ETS gene family in blood clam Tegillarca granosa.
Autorzy:: Jin H; School of Marine Sciences, Ningbo University, Ningbo, 315000, China.; Zhejiang Key Laboratory of Aquatic Germplasm Resources, College of Biological & Environmental Sciences, Zhejiang Wanli University, Zhejiang, 315100, China.
Zhang W; School of Marine Sciences, Ningbo University, Ningbo, 315000, China.
Liu H; Zhejiang Key Laboratory of Aquatic Germplasm Resources, College of Biological & Environmental Sciences, Zhejiang Wanli University, Zhejiang, 315100, China. .
Bao Y; Zhejiang Key Laboratory of Aquatic Germplasm Resources, College of Biological & Environmental Sciences, Zhejiang Wanli University, Zhejiang, 315100, China. .; Pokaż więcej
Źródło:: BMC genomics [BMC Genomics] 2023 Nov 21; Vol. 24 (1), pp. 700. Date of Electronic Publication: 2023 Nov 21.
Typ publikacji:: Journal Article
MeSH Terms:: Arcidae*/genetics
Arcidae*/metabolism
Bivalvia*/genetics
Humans ; Animals ; Phylogeny ; Proto-Oncogene Proteins c-ets/genetics ; Proto-Oncogene Proteins c-ets/metabolism ; Genome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Functional analysis of germline ETV6 W380R mutation causing inherited thrombocytopenia and secondary acute lymphoblastic leukemia or essential thrombocythemia.
Autorzy:: Kozubik KS; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic.; Department of Internal Medicine - Haematology and Oncology, University Hospital and Medical Faculty, Masaryk University, Brno, Czech Republic.
Radova L; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic.
Reblova K; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic.; Department of Internal Medicine - Haematology and Oncology, University Hospital and Medical Faculty, Masaryk University, Brno, Czech Republic.
Smida M; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic.; Department of Internal Medicine - Haematology and Oncology, University Hospital and Medical Faculty, Masaryk University, Brno, Czech Republic.
Zaliova Kubricanova M; Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
Baloun J; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic.
Pesova M; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic.; Department of Internal Medicine - Haematology and Oncology, University Hospital and Medical Faculty, Masaryk University, Brno, Czech Republic.
Vrzalova Z; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic.
Folber F; Department of Internal Medicine - Haematology and Oncology, University Hospital and Medical Faculty, Masaryk University, Brno, Czech Republic.
Mejstrikova S; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic.; Department of Internal Medicine - Haematology and Oncology, University Hospital and Medical Faculty, Masaryk University, Brno, Czech Republic.
Pospisilova S; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic.; Department of Internal Medicine - Haematology and Oncology, University Hospital and Medical Faculty, Masaryk University, Brno, Czech Republic.
Doubek M; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University (CEITEC MU), Brno, Czech Republic.; Department of Internal Medicine - Haematology and Oncology, University Hospital and Medical Faculty, Masaryk University, Brno, Czech Republic.; Pokaż więcej
Źródło:: Platelets [Platelets] 2021 Aug 18; Vol. 32 (6), pp. 838-841. Date of Electronic Publication: 2020 Aug 21.
Typ publikacji:: Journal Article
MeSH Terms:: Germ-Line Mutation/*genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*genetics
Proto-Oncogene Proteins c-ets/*metabolism
Repressor Proteins/*metabolism
Thrombocythemia, Essential/*genetics
Thrombocytopenia/*metabolism
Humans ; ETS Translocation Variant 6 Protein

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: The gene expression level of m6A catalytic enzymes is increased in ETV6/RUNX1-positive acute lymphoblastic leukemia.
Autorzy:: Wang Y; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China.
Zeng HM; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China.
Xue YJ; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China.
Lu AD; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China.
Jia YP; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China.
Zuo YX; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China.
Zhang LP; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China.; Pokaż więcej
Źródło:: International journal of laboratory hematology [Int J Lab Hematol] 2021 Apr; Vol. 43 (2), pp. e89-e91. Date of Electronic Publication: 2020 Nov 10.
Typ publikacji:: Letter
MeSH Terms:: Gene Expression Regulation, Enzymologic*
Gene Expression Regulation, Leukemic*
Adenosine/*analogs & derivatives
Core Binding Factor Alpha 2 Subunit/*genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*genetics
Proto-Oncogene Proteins c-ets/*genetics
Repressor Proteins/*genetics
Adenosine/metabolism ; Catalysis ; Core Binding Factor Alpha 2 Subunit/metabolism ; Humans ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/enzymology ; Proto-Oncogene Proteins c-ets/metabolism ; Repressor Proteins/metabolism ; ETS Translocation Variant 6 Protein

Opinia redakcyjna

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Acute myeloid leukemia carrying ETV6 mutations: biologic and clinical features.
Autorzy:: Zhou F; a Department of Hematology and Oncology, Zhongda Hospital, Medical School , Southeast University , Nanjing , People's Republic of China.
Chen B; a Department of Hematology and Oncology, Zhongda Hospital, Medical School , Southeast University , Nanjing , People's Republic of China.; Pokaż więcej
Źródło:: Hematology (Amsterdam, Netherlands) [Hematology] 2018 Oct; Vol. 23 (9), pp. 608-612. Date of Electronic Publication: 2018 Jun 12.
Typ publikacji:: Journal Article; Review; Systematic Review
MeSH Terms:: Gene Rearrangement*
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/metabolism
Leukemia, Myeloid, Acute*/pathology
Mutation*
Oncogene Proteins, Fusion*/antagonists & inhibitors
Oncogene Proteins, Fusion*/genetics
Oncogene Proteins, Fusion*/metabolism
Proto-Oncogene Proteins c-ets*/genetics
Proto-Oncogene Proteins c-ets*/metabolism
Repressor Proteins*/genetics
Repressor Proteins*/metabolism
Tumor Microenvironment*
Benzamides/therapeutic use ; Humans ; Indazoles/therapeutic use ; Staurosporine/analogs & derivatives ; Staurosporine/therapeutic use ; ETS Translocation Variant 6 Protein

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities.
Autorzy:: Mehtonen J; Institute of Biomedicine, School of Medicine, University of Eastern Finland, Yliopistonranta 1, FI-70211, Kuopio, Finland.
Teppo S; BioMediTech, Faculty of Medicine and Health Technology, Tampere University, FI-33014, Tampere, Finland.
Lahnalampi M; Institute of Biomedicine, School of Medicine, University of Eastern Finland, Yliopistonranta 1, FI-70211, Kuopio, Finland.
Kokko A; Institute of Biomedicine, School of Medicine, University of Eastern Finland, Yliopistonranta 1, FI-70211, Kuopio, Finland.
Kaukonen R; Turku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland.
Oksa L; BioMediTech, Faculty of Medicine and Health Technology, Tampere University, FI-33014, Tampere, Finland.
Bouvy-Liivrand M; Institute of Biomedicine, School of Medicine, University of Eastern Finland, Yliopistonranta 1, FI-70211, Kuopio, Finland.
Malyukova A; Department of Cell and Molecular Biology, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
Mäkinen A; BioMediTech, Faculty of Medicine and Health Technology, Tampere University, FI-33014, Tampere, Finland.
Laukkanen S; BioMediTech, Faculty of Medicine and Health Technology, Tampere University, FI-33014, Tampere, Finland.
Mäkinen PI; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Yliopistonranta 1, FI-70211, Kuopio, Finland.
Rounioja S; Fimlab Laboratories, FI-33520, Tampere, Finland.
Ruusuvuori P; BioMediTech, Faculty of Medicine and Health Technology, Tampere University, FI-33014, Tampere, Finland.
Sangfelt O; Department of Cell and Molecular Biology, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
Lund R; Turku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland.
Lönnberg T; Turku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland.
Lohi O; BioMediTech, Faculty of Medicine and Health Technology, Tampere University, FI-33014, Tampere, Finland.; Tays Cancer Centre, Tampere University Hospital, Tampere, Finland.
Heinäniemi M; Institute of Biomedicine, School of Medicine, University of Eastern Finland, Yliopistonranta 1, FI-70211, Kuopio, Finland. .; Pokaż więcej
Źródło:: Genome medicine [Genome Med] 2020 Nov 20; Vol. 12 (1), pp. 99. Date of Electronic Publication: 2020 Nov 20.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cell Proliferation*
Cell Differentiation/*genetics
Core Binding Factor Alpha 2 Subunit/*genetics
Leukemia/*genetics
Lymphocytes/*physiology
Proto-Oncogene Proteins c-ets/*genetics
Repressor Proteins/*genetics
Bone Marrow ; Cell Line, Tumor ; Child ; Core Binding Factor Alpha 2 Subunit/metabolism ; Drug Delivery Systems ; Gene Expression Regulation, Neoplastic ; Genetic Predisposition to Disease ; Genome-Wide Association Study ; Humans ; Leukemia/drug therapy ; Proto-Oncogene Proteins c-ets/metabolism ; Repressor Proteins/metabolism ; Transcription Factors ; Transcriptome ; Translocation, Genetic ; ETS Translocation Variant 6 Protein

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Integrative genomic analyses reveal putative cell type-specific targets of the Drosophila ets transcription factor Pointed.
Autorzy:: Bollepogu Raja KK; Department of Pathology and Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, TX, 77030, USA.
Yeung K; Department of Pathology and Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, TX, 77030, USA.
Shim YK; Department of Pathology and Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, TX, 77030, USA.
Mardon G; Department of Pathology and Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, TX, 77030, USA. .; Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX, 77030, USA. .; Pokaż więcej
Źródło:: BMC genomics [BMC Genomics] 2024 Jan 23; Vol. 25 (1), pp. 103. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:: Journal Article
MeSH Terms:: Drosophila*
Genomics*
Animals ; Cell Differentiation ; ErbB Receptors ; Larva ; Proto-Oncogene Proteins c-ets

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: ETV6::ABL1 -Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment.
Autorzy:: Bochicchio MT; Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.
Marconi G; Hematology Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.
Baldazzi C; Istituto di Ematologia 'Seràgnoli', IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy.
Bandini L; Istituto di Ematologia 'Seràgnoli', IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy.
Ruggieri F; Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40100 Bologna, BO, Italy.
Lucchesi A; Hematology Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.
Agostinelli C; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40100 Bologna, BO, Italy.; Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy.
Sabattini E; Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy.
Orsatti A; Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy.
Ferrari A; Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.
Capirossi G; Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.
Servili C; Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.
Ghelli Luserna di Rorà A; Fondazione Pisana per la Scienza ONLUS, 56017 San Giuliano Terme, PI, Italy.
Martinelli G; Scientific Directorate, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.
Simonetti G; Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.
Rosti G; Hematology Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) 'Dino Amadori', 47014 Meldola, FC, Italy.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 21; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:: Case Reports
MeSH Terms:: Myeloproliferative Disorders*
Hypereosinophilic Syndrome*
Neoplasms*
Female ; Humans ; Middle Aged ; Imatinib Mesylate/therapeutic use ; Protein Kinase Inhibitors ; Cytogenetics ; Proto-Oncogene Proteins c-ets/genetics

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: ZBTB46 , SPDEF , and ETV6 : Novel Potential Biomarkers and Therapeutic Targets in Castration-Resistant Prostate Cancer.
Autorzy:: Fararjeh AS; PhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan. .
Liu YN; PhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan. .; Graduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan. .; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan. .; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2019 Jun 08; Vol. 20 (11). Date of Electronic Publication: 2019 Jun 08.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Biomarkers, Tumor/*metabolism
Prostatic Neoplasms, Castration-Resistant/*metabolism
Proto-Oncogene Proteins c-ets/*metabolism
Repressor Proteins/*metabolism
Transcription Factors/*metabolism
Animals ; Biomarkers, Tumor/genetics ; Humans ; Male ; Prostatic Neoplasms, Castration-Resistant/genetics ; Prostatic Neoplasms, Castration-Resistant/pathology ; Proto-Oncogene Proteins c-ets/genetics ; Repressor Proteins/genetics ; Signal Transduction ; Transcription Factors/genetics ; ETS Translocation Variant 6 Protein

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Evidence for a role of RUNX1 as recombinase cofactor for TCRβ rearrangements and pathological deletions in ETV6-RUNX1 ALL.
Autorzy:: Seitz V; Charité University Medicine Berlin, Institute of Pathology, Berlin, Germany.; HS Diagnomics GmbH, Berlin, Germany.
Kleo K; Charité University Medicine Berlin, Institute of Pathology, Berlin, Germany.
Dröge A; HS Diagnomics GmbH, Berlin, Germany.
Schaper S; HS Diagnomics GmbH, Berlin, Germany.
Elezkurtaj S; Charité University Medicine Berlin, Institute of Pathology, Berlin, Germany.
Bedjaoui N; University of Paris, Institute Necker-Enfants Malades (INEM), INSERM U1151, Laboratoire d'Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, France.
Dimitrova L; Charité University Medicine Berlin, Institute of Pathology, Berlin, Germany.
Sommerfeld A; Charité University Medicine Berlin, Institute of Pathology, Berlin, Germany.
Berg E; Charité University Medicine Berlin, Institute of Pathology, Berlin, Germany.
von der Wall E; Charité University Medicine Berlin, Institute of Pathology, Berlin, Germany.
Müller U; Heinrich-Pette-Institute, Leibniz-Institute for Experimental Virology, Hamburg, Germany.
Joosten M; Charité University Medicine Berlin, Institute of Pathology, Berlin, Germany.
Lenze D; Charité University Medicine Berlin, Institute of Pathology, Berlin, Germany.
Heimesaat MM; Charité University Medicine Berlin, Institute of Microbiology, Infectious Diseases and Immunology, Berlin, Germany.
Baldus C; University Medical Center Schleswig-Holstein, Department of Internal Medicine II, Kiel, Germany.
Zinser C; Precigen Bioinformatics Germany GmbH, Munich, Germany.
Cieslak A; University of Paris, Institute Necker-Enfants Malades (INEM), INSERM U1151, Laboratoire d'Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, France.
Macintyre E; University of Paris, Institute Necker-Enfants Malades (INEM), INSERM U1151, Laboratoire d'Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, France.
Stocking C; University Medical Center Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany.
Hennig S; HS Diagnomics GmbH, Berlin, Germany.
Hummel M; Charité University Medicine Berlin, Institute of Pathology, Berlin, Germany. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2020 Jun 22; Vol. 10 (1), pp. 10024. Date of Electronic Publication: 2020 Jun 22.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Gene Deletion*
Core Binding Factor Alpha 2 Subunit/*physiology
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor/*genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*genetics
Proto-Oncogene Proteins c-ets/*genetics
Receptors, Antigen, T-Cell, alpha-beta/*genetics
Repressor Proteins/*genetics
Animals ; B-Lymphocytes ; Core Binding Factor Alpha 2 Subunit/genetics ; Lymphocyte Count ; Mice, Knockout ; T-Lymphocytes ; Thymus Gland/pathology ; ETS Translocation Variant 6 Protein

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma.
Autorzy:: Guo C; Department of Biotechnology, College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, China.
Gao C; Department of Biotechnology, College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, China.
Zhao D; Department of Biotechnology, College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, China.
Li J; Department of Biochemistry, College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, China.
Wang J; Department of Biotechnology, College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, China.
Sun X; Department of Biotechnology, College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, China.
Liu Q; Department of General Surgery, The Second Affiliated Hospital, Dalian Medical University, Dalian, 116044, China.
Hao L; Department of Histology and Embryology, College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, China.
Greenaway FT; Carlson School of Chemistry and Biochemistry, Clark University, Worcester, MA, 01610, USA.
Tian Y; Department of Biochemistry, College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, China.
Liu S; Department of Biochemistry, College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, China. .
Sun MZ; Department of Biotechnology, College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2020 Apr 23; Vol. 39 (1), pp. 70. Date of Electronic Publication: 2020 Apr 23.
Typ publikacji:: Journal Article
MeSH Terms:: Adaptor Proteins, Signal Transducing/*genetics
Carcinoma, Hepatocellular/*genetics
Liver Neoplasms/*genetics
MicroRNAs/*genetics
Proto-Oncogene Proteins c-ets/*genetics
Repressor Proteins/*genetics
Adaptor Proteins, Signal Transducing/biosynthesis ; Carcinoma, Hepatocellular/metabolism ; Carcinoma, Hepatocellular/pathology ; Cell Line, Tumor ; Cell Movement/physiology ; Cell Proliferation/physiology ; Female ; Gene Expression Regulation, Neoplastic ; Hep G2 Cells ; Humans ; Liver Neoplasms/metabolism ; Liver Neoplasms/pathology ; Male ; MicroRNAs/biosynthesis ; Middle Aged ; Proto-Oncogene Proteins c-ets/biosynthesis ; Repressor Proteins/biosynthesis ; Transfection ; ETS Translocation Variant 6 Protein

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: ETV6 / RUNX1 Fusion Gene Abrogation Decreases the Oncogenicity of Tumour Cells in a Preclinical Model of Acute Lymphoblastic Leukaemia.
Autorzy:: Montaño A; IBSAL, IBMCC, Cancer Research Center, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain.
Ordoñez JL; IBSAL, IBMCC, Cancer Research Center, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain.; Dept of Biochemistry and Molecular Biology, University of Salamanca, Campus Unamuno s/n, 37007 Salamanca, Spain.
Alonso-Pérez V; IBSAL, IBMCC, Cancer Research Center, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain.
Hernández-Sánchez J; IBSAL, IBMCC, Cancer Research Center, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain.
Santos S; IBSAL, IBMCC, Cancer Research Center, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain.
González T; IBSAL, IBMCC, Cancer Research Center, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain.; Department of Hematology, Hospital Universitario de Salamanca, 37007 Salamanca, Spain.
Benito R; IBSAL, IBMCC, Cancer Research Center, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain.
García-Tuñón I; IBSAL, IBMCC, Cancer Research Center, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain.
Hernández-Rivas JM; IBSAL, IBMCC, Cancer Research Center, Universidad de Salamanca-CSIC, 37007 Salamanca, Spain.; Department of Hematology, Hospital Universitario de Salamanca, 37007 Salamanca, Spain.; Department of Medicine, Universidad de Salamanca and CIBERONC, 37007 Salamanca, Spain.; Pokaż więcej
Źródło:: Cells [Cells] 2020 Jan 15; Vol. 9 (1). Date of Electronic Publication: 2020 Jan 15.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Models, Biological*
Core Binding Factor Alpha 2 Subunit/*metabolism
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*metabolism
Proto-Oncogene Proteins c-ets/*metabolism
Repressor Proteins/*metabolism
CRISPR-Associated Protein 9/genetics ; CRISPR-Associated Protein 9/metabolism ; Cell Proliferation ; Core Binding Factor Alpha 2 Subunit/deficiency ; Core Binding Factor Alpha 2 Subunit/genetics ; Gene Editing ; Humans ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Proto-Oncogene Proteins c-ets/deficiency ; Proto-Oncogene Proteins c-ets/genetics ; Repressor Proteins/deficiency ; Repressor Proteins/genetics ; Tumor Cells, Cultured ; ETS Translocation Variant 6 Protein

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: ELK4 Promotes Cell Cycle Progression and Stem Cell-like Characteristics in HPV-associated Cervical Cancer by Regulating the FBXO22/PTEN Axis
Autorzy:: Gao F; Department of Gynecology, Cangzhou People’s Hospital, Cangzhou, China
Wang C; Department of Gynecology, Cangzhou People’s Hospital, Cangzhou, China
Bai X; Department of Gynecology, Cangzhou People’s Hospital, Cangzhou, China
Ji J; Department of Gynecology, Cangzhou People’s Hospital, Cangzhou, China
Huang X; Department of Gynecology, Cangzhou People’s Hospital, Cangzhou, China; Pokaż więcej
Źródło:: Balkan medical journal [Balkan Med J] 2023 Oct 20; Vol. 40 (6), pp. 409-414. Date of Electronic Publication: 2023 Jul 31.
Typ publikacji:: Journal Article
MeSH Terms:: Uterine Cervical Neoplasms*/metabolism
Papillomavirus Infections*
F-Box Proteins*/pharmacology
Female ; Humans ; Human Papillomavirus Viruses ; Cell Line, Tumor ; Cell Proliferation ; Stem Cells/metabolism ; Stem Cells/pathology ; Cell Cycle ; PTEN Phosphohydrolase/metabolism ; PTEN Phosphohydrolase/pharmacology ; ets-Domain Protein Elk-4/metabolism ; Receptors, Cytoplasmic and Nuclear/metabolism ; Receptors, Cytoplasmic and Nuclear/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: RNA binding protein IGF2BP1 synergizes with ETV6-RUNX1 to drive oncogenic signaling in B-cell Acute Lymphoblastic Leukemia.
Autorzy:: Sharma G; Department of Biochemistry, All India Institute of Medical Sciences, Room 4008, Convergence Block, New Delhi, 110029, India.
Tran TM; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Bansal I; Department of Biochemistry, All India Institute of Medical Sciences, Room 4008, Convergence Block, New Delhi, 110029, India.
Beg MS; Department of Biochemistry, All India Institute of Medical Sciences, Room 4008, Convergence Block, New Delhi, 110029, India.
Bhardwaj R; Department of Biochemistry, All India Institute of Medical Sciences, Room 4008, Convergence Block, New Delhi, 110029, India.
Bassi J; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Tan Y; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Jaiswal AK; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Tso C; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Jain A; Department of Biochemistry, All India Institute of Medical Sciences, Room 4008, Convergence Block, New Delhi, 110029, India.
Singh J; Department of Laboratory Oncology, Dr B.R Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
Chattopadhyay P; Department of Biochemistry, All India Institute of Medical Sciences, Room 4008, Convergence Block, New Delhi, 110029, India.
Singh A; Department of Biochemistry, All India Institute of Medical Sciences, Room 4008, Convergence Block, New Delhi, 110029, India.
Chopra A; Department of Laboratory Oncology, Dr B.R Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
Bakhshi S; Department of Medical Oncology, Dr B.R Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India.
Casero D; F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Rao DS; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA.
Palanichamy JK; Department of Biochemistry, All India Institute of Medical Sciences, Room 4008, Convergence Block, New Delhi, 110029, India. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Sep 05; Vol. 42 (1), pp. 231. Date of Electronic Publication: 2023 Sep 05.
Typ publikacji:: Journal Article
MeSH Terms:: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
Animals ; Mice ; Core Binding Factor Alpha 2 Subunit ; Mice, Knockout ; Phosphatidylinositol 3-Kinases ; ETS Translocation Variant 6 Protein

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Coexpression of ETV6/MDS1/EVI1 and ETV6/EVI1 fusion transcripts in acute myeloid leukemia with t(3;12)(q26.2;p13) and thrombocytosis.
Autorzy:: Yamamoto K; a Division of Medical Oncology/Hematology, Department of Medicine , Kobe University Graduate School of Medicine , Kobe , Japan.
Yakushijin K; a Division of Medical Oncology/Hematology, Department of Medicine , Kobe University Graduate School of Medicine , Kobe , Japan.
Ichikawa H; a Division of Medical Oncology/Hematology, Department of Medicine , Kobe University Graduate School of Medicine , Kobe , Japan.
Okamura A; a Division of Medical Oncology/Hematology, Department of Medicine , Kobe University Graduate School of Medicine , Kobe , Japan.
Nagao S; a Division of Medical Oncology/Hematology, Department of Medicine , Kobe University Graduate School of Medicine , Kobe , Japan.
Kakiuchi S; a Division of Medical Oncology/Hematology, Department of Medicine , Kobe University Graduate School of Medicine , Kobe , Japan.
Kurata K; a Division of Medical Oncology/Hematology, Department of Medicine , Kobe University Graduate School of Medicine , Kobe , Japan.
Kawamoto S; a Division of Medical Oncology/Hematology, Department of Medicine , Kobe University Graduate School of Medicine , Kobe , Japan.
Matsui K; b Department of Clinical Laboratory , Kobe University Hospital , Kobe , Japan.
Nakamachi Y; b Department of Clinical Laboratory , Kobe University Hospital , Kobe , Japan.
Saegusa J; b Department of Clinical Laboratory , Kobe University Hospital , Kobe , Japan.
Matsuoka H; b Department of Clinical Laboratory , Kobe University Hospital , Kobe , Japan.
Minami H; b Department of Clinical Laboratory , Kobe University Hospital , Kobe , Japan.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2019 May; Vol. 60 (5), pp. 1294-1298. Date of Electronic Publication: 2018 Dec 11.
Typ publikacji:: Case Reports; Letter
MeSH Terms:: Gene Expression Regulation, Leukemic*
Translocation, Genetic*
Leukemia, Myeloid, Acute/*genetics
MDS1 and EVI1 Complex Locus Protein/*genetics
Oncogene Proteins, Fusion/*genetics
Proto-Oncogene Proteins c-ets/*genetics
Repressor Proteins/*genetics
Thrombocytosis/*genetics
Bone Marrow/pathology ; Cell Line, Tumor ; Chromosomes, Human, Pair 12 ; Chromosomes, Human, Pair 3 ; DNA Mutational Analysis ; Humans ; Karyotype ; Male ; Young Adult ; ETS Translocation Variant 6 Protein

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""ETS"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji